Testing effectiveness (Phase 2)Study completedNCT04687761
What this trial is testing
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old
Who this might be right for
Leukemia, Myeloid, AcuteDe NovoAge More 60yr
PETHEMA Foundation 113